Serum antibodies to LDH-C4

Area of Science:

• Immunology
• Reproductive Biology
• Contraception Research

Background:

• Sperm-specific lactate dehydrogenase (LDH-C4) is a potential target for immunocontraception.
• Assays for detecting anti-LDH-C4 antibodies are crucial for evaluating its contraceptive potential.

Purpose of the Study:

• To quantify antibodies against the sperm-specific lactate dehydrogenase (LDH-C4) in human sera.
• To assess the correlation of anti-LDH-C4 antibodies with infertility and vasectomy.
• To evaluate the potential of LDH-C4 as a target for contraceptive vaccine development.

Main Methods:

• Human sera from the WHO Reference Bank were analyzed using a liquid phase radioimmunoassay.
• The assay specifically targeted antibodies against the sperm-specific form of lactate dehydrogenase (LDH-C4).

Main Results:

• Modestly elevated levels of anti-LDH-C4 antibodies were found in approximately 10% of infertile individuals (males and females) and 20% of vasectomized males.
• The presence of anti-LDH-C4 activity showed no clear correlation with other anti-sperm antibody assays.
• The radioimmunometric assay demonstrated absolute specificity for the sperm antigen LDH-C4.

Conclusions:

• The detection of anti-LDH-C4 antibodies in specific human populations suggests its immunogenic potential.
• These findings provide support for the development of contraceptive vaccines utilizing the LDH-C4 antigen.
• LDH-C4 represents a promising target for future immunocontraceptive strategies.